About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

First Human Trials Of Alzheimer's Drug

by Colleen Fleiss on May 29, 2018 at 1:35 AM
First Human Trials Of Alzheimer's Drug

UK is set to launch the first human trials of ground-breaking drug shown to repair DNA damage that contributes to Alzheimer's disease, reported sources.

The study, also being launched this week in hospitals in France and Spain, will see the neuro-degenerative condition treated with an agent which acts as a DNA repair kit to restore memory and reverse behavioural changes such as aggression and social avoidance, the express.co.uk reported late on Sunday.

Advertisement


The drug, known as ORY-2001, contains a small molecule which inhibits two enzymes in the brain, LSD1, and MAOB, which are responsible for promoting DNA damage and inhibiting repair.

By blocking their action, the new drug repairs and prevents further damage.

The drug also stops inflammation in the brain, a key factor perhaps causing mental decline, the report said.
Advertisement

"Curing Alzheimer's is now on the horizon. The mechanism of this drug may lead to treatments that protect genetic material from the influences of ageing," Stuart Ratcliffe, chief scientific officer at St Pancras Clinical Research in London, was quoted as saying.

"I believe this is ground-breaking. Neuro-degenerative diseases are a massive problem so heading these off is a holy grail of medicine," Ratcliffe added.

Tests on mice have shown that one treatment a day can reverse the disease, giving new hope that a cure is on the horizon.

"Alzheimer's is our biggest killer and is spiralling," Ratcliffe said.

"It is therefore paramount that new treatments are discovered and developed, otherwise the societal and health care costs of Alzheimer's alone could bankrupt us," he added.

Source: IANS
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Clinical Trials News

'Artificial Wombs' In Human Trials Awaits FDA Approval
FDA approval is sought for “artificial womb” clinical trials (mimicking lamb trials) in humans, that can potentially reduce mortality in premature babies.
Injecting Platelets Could be as Beneficial as Exercising to the Brain
Increasing the levels of platelet-derived factors in the body may lessen the effect of age-related degenerative changes and cognitive impairment in the brain.
Engineered Bacteria Offer New Hope for Early Cancer Detection
Constructing bacteria to become drug resistant only when they took up DNA containing cancer-associated changes, could be useful in detecting cancer.
Is Eli Lilly's Drug the Future of Obesity Treatment?
Eli Lilly's Mounjaro may prove an alternative to bariatric surgery, stated clinical trial results.
Made In India 'Liquid Cornea' Will Soon Undergo Human Trial
After achieving an 80 percent success rate in treating animals, Indian doctors plan to advance to human trials for the liquid cornea.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

First Human Trials Of Alzheimer's Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests